{"id":"https://openalex.org/W4362524852","doi":"https://doi.org/10.1158/1538-7445.am2023-4552","title":"Abstract 4552: 3D-EXplore platform of fresh patient tumoroids with intact TME allows assessment of the efficacy of drugs targeting the tumor stroma on ex vivo tumor immunotherapy","display_name":"Abstract 4552: 3D-EXplore platform of fresh patient tumoroids with intact TME allows assessment of the efficacy of drugs targeting the tumor stroma on ex vivo tumor immunotherapy","publication_year":2023,"publication_date":"2023-04-04","ids":{"openalex":"https://openalex.org/W4362524852","doi":"https://doi.org/10.1158/1538-7445.am2023-4552"},"language":"en","primary_location":{"id":"doi:10.1158/1538-7445.am2023-4552","doi":"https://doi.org/10.1158/1538-7445.am2023-4552","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.am2023-4552","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5058574624","display_name":"Seth Currlin","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Seth Currlin","raw_affiliation_strings":["1Nilogen Oncosystems, Tampa, FL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Nilogen Oncosystems, Tampa, FL","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5009329677","display_name":"Brittney Ruedlinger","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Brittney Ruedlinger","raw_affiliation_strings":["1Nilogen Oncosystems, Tampa, FL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Nilogen Oncosystems, Tampa, FL","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5001295137","display_name":"Sharon Camacho","orcid":"https://orcid.org/0000-0003-2390-0880","observed_orcids":["https://orcid.org/0000-0003-2390-0880"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Sharon Camacho","raw_affiliation_strings":["1Nilogen Oncosystems, Tampa, FL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Nilogen Oncosystems, Tampa, FL","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5020603475","display_name":"Angie Rivera","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Angie Rivera","raw_affiliation_strings":["1Nilogen Oncosystems, Tampa, FL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Nilogen Oncosystems, Tampa, FL","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5019554814","display_name":"Jasmin D\u2019Andrea","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jasmin D'Andrea","raw_affiliation_strings":["1Nilogen Oncosystems, Tampa, FL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Nilogen Oncosystems, Tampa, FL","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5042557844","display_name":"Jared C. Ehrhart","orcid":"https://orcid.org/0000-0003-0679-4684","observed_orcids":["https://orcid.org/0000-0003-0679-4684"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jared Ehrhart","raw_affiliation_strings":["1Nilogen Oncosystems, Tampa, FL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Nilogen Oncosystems, Tampa, FL","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5043205942","display_name":"Soner Altiok","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Soner Altiok","raw_affiliation_strings":["1Nilogen Oncosystems, Tampa, FL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Nilogen Oncosystems, Tampa, FL","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":2,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"83","issue":"7_Supplement","first_page":"4552","last_page":"4552"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.5419999957084656,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.5419999957084656,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10336","display_name":"Cancer Cells and Metastasis","score":0.36059999465942383,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11501","display_name":"TGF-\u03b2 signaling in diseases","score":0.025299999862909317,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/tumor-organoids","display_name":"tumor organoids","score":0.7379999756813049},{"id":"https://openalex.org/keywords/tumor-microenvironment","display_name":"tumor microenvironment","score":0.925000011920929},{"id":"https://openalex.org/keywords/cancer-associated-fibroblasts","display_name":"cancer-associated fibroblasts","score":0.9350000023841858},{"id":"https://openalex.org/keywords/tumor-stroma-targeting","display_name":"tumor stroma targeting","score":0.9160000085830688},{"id":"https://openalex.org/keywords/nivolumab","display_name":"nivolumab","score":0.9089999794960022},{"id":"https://openalex.org/keywords/immune-checkpoint-blockade","display_name":"immune checkpoint blockade","score":0.9359999895095825},{"id":"https://openalex.org/keywords/tumor-cell-killing","display_name":"tumor cell killing","score":0.7689999938011169},{"id":"https://openalex.org/keywords/tgf-beta-inhibition","display_name":"TGF-beta inhibition","score":0.7649999856948853},{"id":"https://openalex.org/keywords/galunisertib","display_name":"galunisertib","score":0.8880000114440918},{"id":"https://openalex.org/keywords/fak-inhibitors","display_name":"FAK inhibitors","score":0.7459999918937683},{"id":"https://openalex.org/keywords/defactinib","display_name":"defactinib","score":0.8769999742507935},{"id":"https://openalex.org/keywords/plerixafor","display_name":"plerixafor","score":0.9710000157356262},{"id":"https://openalex.org/keywords/endometrial-cancer","display_name":"endometrial cancer","score":0.7229999899864197},{"id":"https://openalex.org/keywords/ovarian-cancer","display_name":"ovarian cancer","score":0.9990000128746033},{"id":"https://openalex.org/keywords/colorectal-cancer","display_name":"colorectal cancer","score":0.9990000128746033},{"id":"https://openalex.org/keywords/t-cell-activation","display_name":"T cell activation","score":0.41600000858306885}],"concepts":[{"id":"https://openalex.org/C26291073","wikidata":"https://www.wikidata.org/wiki/Q310484","display_name":"Ex vivo","level":3,"score":0.7715277671813965},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.6577756404876709},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6414995193481445},{"id":"https://openalex.org/C16930146","wikidata":"https://www.wikidata.org/wiki/Q4381253","display_name":"Stromal cell","level":2,"score":0.6093988418579102},{"id":"https://openalex.org/C2776107976","wikidata":"https://www.wikidata.org/wiki/Q1786433","display_name":"Tumor microenvironment","level":3,"score":0.5744001269340515},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.4824103116989136},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.456605464220047},{"id":"https://openalex.org/C2780030458","wikidata":"https://www.wikidata.org/wiki/Q7041828","display_name":"Nivolumab","level":4,"score":0.4496104419231415},{"id":"https://openalex.org/C52124034","wikidata":"https://www.wikidata.org/wiki/Q557179","display_name":"Stroma","level":3,"score":0.4371332824230194},{"id":"https://openalex.org/C207001950","wikidata":"https://www.wikidata.org/wiki/Q141124","display_name":"In vivo","level":2,"score":0.39080342650413513},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.3676965832710266},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.3276742100715637},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.17965081334114075},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.1335429549217224},{"id":"https://openalex.org/C204232928","wikidata":"https://www.wikidata.org/wiki/Q899285","display_name":"Immunohistochemistry","level":2,"score":0.0},{"id":"https://openalex.org/C150903083","wikidata":"https://www.wikidata.org/wiki/Q7108","display_name":"Biotechnology","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/1538-7445.am2023-4552","doi":"https://doi.org/10.1158/1538-7445.am2023-4552","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.am2023-4552","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9907000064849854,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W3025356948","https://openalex.org/W2030994367","https://openalex.org/W7167872164","https://openalex.org/W3113549876","https://openalex.org/W3196899817","https://openalex.org/W2789000098","https://openalex.org/W2014016859","https://openalex.org/W2766747032","https://openalex.org/W7162769243","https://openalex.org/W4313339714"],"abstract_inverted_index":{"Abstract":[0],"Introduction:":[1],"Cancer":[2,381,400],"associated":[3,210],"fibroblasts":[4],"(CAFs)":[5],"are":[6],"a":[7,81,185,228,270],"major":[8],"component":[9],"of":[10,27,44,64,98,204,235,316,328,350,359,362,376],"the":[11,74,94,101,157,202,222,243,263,314,326,360,365,377],"tumormicroenvironment":[12],"(TME)":[13],"and":[14,58,96,114,143,163,191,197,209,251,297,302,320,323,389],"exhibit":[15],"diverse":[16],"tumorigenic":[17],"functions":[18],"such":[19],"as":[20,214,216,255,257],"immunosuppressionand":[21],"extracellular":[22],"matrix":[23],"(ECM)":[24],"remodeling.":[25],"Treatment":[26],"solid":[28,45],"tumors":[29,46,139,322],"is":[30,52],"often":[31],"hindered":[32],"by":[33,269],"acomplex":[34],"TME,":[35],"which":[36],"persists":[37],"despite":[38],"effective":[39],"tumor-cell":[40],"directed":[41],"therapies.":[42],"Therefore,treatment":[43],"in":[47,69,80,133,221,262,293],"combination":[48,70,234],"with":[49,71,108,122,150,171,299,354],"stromal-targeting":[50],"therapies":[51],"essential":[53],"toovercome":[54],"CAF-facilitated":[55],"tumor":[56,65,118,187,211,264,366,371],"growth,":[57],"immunosuppression.":[59],"Herein":[60],"we":[61,200,226],"interrogate":[62],"theimpact":[63],"stroma":[66,367],"targeting":[67,152,206,237,364],"therapeutics,":[68],"nivolumab,":[72],"on":[73,242,258,368],"efficacy":[75,361],"oftumor":[76,245],"cell":[77,164,188,212,253],"killing":[78,189,213],"(TCK)":[79],"3D":[82,128],"human":[83],"tumoroid":[84,223,294],"ex":[85,175,180,369],"vivo":[86,181,370],"culture":[87,295],"model":[88],"(3D-EXplore).":[89],"Resultingdata":[90],"suggests":[91],"that":[92],"impairing":[93],"recruitment":[95],"activation":[97,244],"CAFs":[99],"within":[100],"TME":[102,356],"leads":[103],"toenhanced":[104],"TCK":[105],"when":[106],"combined":[107],"immune":[109,218,265],"checkpoint":[110],"blockade":[111],"therapy.":[112],"Materials":[113],"Methods:":[115],"All":[116],"patients":[117],"samples":[119],"were":[120,135],"collected":[121],"patient":[123,352],"consent":[124],"andrelevant":[125],"IRB":[126],"approval.":[127],"tumoroids":[129,353],"measuring":[130],"150":[131],"microns":[132],"size":[134],"generated":[136],"from":[137],"freshpatient":[138],"including":[140],"endometrial,":[141],"ovarian,":[142],"colorectal":[144],"cancer":[145],"tissues.":[146],"Tumoroids":[147],"werethen":[148],"treated":[149],"stromal":[151,205,236],"strategies":[153],"for":[154,173,304,380],"TGF-beta":[155],"(galunisertib),":[156],"FGF":[158],"pathway(Dovitinib),":[159],"FAK":[160],"inhibitors":[161],"(defactinib),":[162],"adhesion":[165],"modulators":[166],"(plerixafor)":[167],"alone":[168],"or":[169],"incombination":[170],"nivolumab":[172],"72-hours":[174],"vivo.":[176],"Tumor":[177],"responses":[178],"to":[179,232],"treatments":[182],"wereassessed":[183],"using":[184],"proprietary":[186],"assay":[190,274],"21-color":[192],"flow":[193,230],"cytometry":[194],"analysis.":[195],"Results":[196],"Summary:":[198],"Here":[199],"evaluated":[201],"impact":[203],"therapeutics":[207],"onCAFs":[208],"well":[215,256],"overcoming":[217],"evasion":[219],"mechanismspreserved":[220],"models.":[224],"Furthermore,":[225],"used":[227],"multicolor":[229],"panel":[231],"analyzewhether":[233],"drugs":[238,363],"enhances":[239],"nivolumab\u2019s":[240],"effect":[241],"resident":[246],"CD4,":[247],"CD8":[248],"T-cells,":[249],"NKT,":[250],"NK":[252],"populations":[254],"macrophagepolarization.":[259],"Treatment-mediated":[260],"changes":[261],"microenvironment":[266,315],"was":[267],"furthercorroborated":[268],"multiplex":[271],"cytokine":[272],"release":[273],"detecting":[275],"GM-CSF,":[276],"sCD137,":[277],"IFN\u03b3,":[278],"sFas,sFasL,":[279],"Granzyme":[280,282],"A,":[281],"B,":[283],"IL-2,":[284],"IL-4,":[285],"IL-5,":[286],"IL-6,":[287],"IL-10,":[288],"IL-13,":[289],"MIP-1\u03b1,":[290],"MIP-1\u03b2,":[291],"TNF-\u03b1,Perforin":[292],"media":[296],"correlated":[298],"clinicopathologic":[300],"findings":[301],"PD-L1expression":[303],"individual":[305],"tumnors.":[306],"Further,":[307],"this":[308],"3D-tumoroid":[309],"platform":[310,349],"provides":[311],"unique":[312],"insightinto":[313],"both":[317],"treatment":[318],"responsive":[319],"non-responsive":[321],"can":[324],"aidin":[325],"development":[327],"patient-centered":[329],"therapeutic":[330],"regimens.":[331],"Citation":[332],"Format:":[333],"Seth":[334],"Currlin,":[335],"Brittney":[336],"Ruedlinger,":[337],"Sharon":[338],"Camacho,":[339],"Angie":[340],"Rivera,":[341],"Jasmin":[342],"D'Andrea,":[343],"Jared":[344],"Ehrhart,":[345],"Soner":[346],"Altiok.":[347],"3D-EXplore":[348],"fresh":[351],"intact":[355],"allows":[357],"assessment":[358],"immunotherapy.":[372],"[abstract].":[373],"In:":[374],"Proceedings":[375],"American":[378],"Association":[379],"Research":[382],"Annual":[383],"Meeting":[384],"2023;":[385],"Part":[386],"1":[387],"(Regular":[388],"Invited":[390],"Abstracts);":[391],"2023":[392],"Apr":[393],"14-19;":[394],"Orlando,":[395],"FL.":[396],"Philadelphia":[397],"(PA):":[398],"AACR;":[399],"Res":[401],"2023;83(7_Suppl):Abstract":[402],"nr":[403],"4552.":[404]},"counts_by_year":[{"year":2025,"cited_by_count":2}],"updated_date":"2026-09-25T08:18:29.962427","created_date":"2023-04-06T00:00:00"}